Trends in Medical Aid in Dying in Oregon and Washington. by Al Rabadi, Luai et al.
UC Irvine
UC Irvine Previously Published Works
Title
Trends in Medical Aid in Dying in Oregon and Washington.
Permalink
https://escholarship.org/uc/item/0699861c
Journal
JAMA network open, 2(8)
ISSN
2574-3805
Authors
Al Rabadi, Luai
LeBlanc, Michael
Bucy, Taylor
et al.
Publication Date
2019-08-02
DOI
10.1001/jamanetworkopen.2019.8648
License
CC BY 4.0
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Original Investigation | Health Policy
Trends inMedical Aid in Dying in Oregon andWashington
Luai Al Rabadi, MD; Michael LeBlanc, PhD; Taylor Bucy, BS; LeeM. Ellis, MD; Dawn L. Hershman, MD, MS; Frank L. Meyskens Jr, MD;
Lynne Taylor, MD; Charles D. Blanke, MD
Abstract
IMPORTANCE The combined 28 years of data of medical aid in dying (MAID) between Oregon (OR)
andWashington (WA) are themost comprehensive in North America. No reports to date have
comparedMAID use in different US states.
OBJECTIVE To evaluate and compare patterns of MAID use between the states with the longest-
running US death with dignity programs.
DESIGN, SETTING, AND PARTICIPANTS A retrospective observational cohort study of OR andWA
patients with terminal illness who received prescriptions as part of their states’ legislation allowing
MAID. All published annual reports, from 1998 to 2017 in OR and from 2009 to 2017 in WA, were
reviewed. A total of 3368 prescriptions were included.
MAINOUTCOMESANDMEASURES Number of deaths from self-administration of lethal
medication vs number of prescriptions written.
RESULTS A combined 3368 prescriptions were written in OR andWA, with 2558 patient deaths
from lethal ingestion (76.0%). Of the 2558 patients, most were male (1311 [51.3%]), older than 65
years (1851 [72.4%]), and non-Hispanic white (2426 [94.8%]). Themost common underlying
illnesses were cancer (1955 [76.4%]), neurologic illness (261 [10.2%]), lung disease (144 [5.6%]), and
heart disease (117 [4.6%]). Loss of autonomy (2235 [87.4%]), impaired quality of life (2203 [86.1%]),
and loss of dignity (1755 [68.6%]) were themost common reasons for pursuingMAID. Time between
drug intake to coma ranged from 1 to 660minutes and time from drug intake to death ranged from
1 to 6240minutes. In the 1557 patients for whom rates of complications were reported, 1494
(96.0%) did not experience a complication (592 of 626 [94.6%] in OR and 902 of 931 [96.8%] in
WA). Eight patients (<0.5%) regained consciousness after drug ingestion in OR. Annual rates per year
for percentage of patients who received a prescription ingesting the prescribedmedication ranged
from 48% to 87%, with no significant time trend in OR (adjusted odds ratio per year, 1.01; 95% CI,
0.99-1.02; P = .59) but with an increase over time in WA (adjusted odds ratio per year, 1.13; 95% CI,
1.08-1.19; P < .001). In both OR and WA there were increases in the number of patient deaths due to
MAID per 1000 deaths over time.
CONCLUSIONS ANDRELEVANCE In this study, MAID results in Oregon andWashington were
similar, althoughMAID usemeasured as a percentage of patients prescribed lethal medications and
then self-administering them increased only in WA. Most patients who acquired lethal prescriptions
had cancer or terminal illnesses that are difficult to palliate and lead to loss of autonomy, dignity, and
quality of life.
JAMA Network Open. 2019;2(8):e198648. doi:10.1001/jamanetworkopen.2019.8648
Key Points
Question Are patterns of medical aid in
dying (MAID) use similar in Oregon and
Washington?
Findings In this cohort study of 3368
prescriptions for MAID in Oregon and
Washington, most patients in both
states were insured, non-Hispanic white
individuals with some level of college
education, with cancer being themost
common underlying illness prompting
MAID request. Annual percentage of
patients per year who were prescribed
medication and ingested it did not
change in Oregon but increased over
time inWashington, and in both states
there were increasing deaths due to
MAID per 1000 deaths over time.
Meaning With the exception of use of
prescribed medication, MAID patterns
are similar in Oregon andWashington.
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Introduction
The Oregon DeathWith Dignity Act, passed in 1994, legally permits terminally ill adults (age18
years) with legal Oregon (OR) residency to make the voluntary informed choice to obtain a
physician’s prescription for oral drugs to end life.1 In 2008,Washington state (WA) approved similar
legislation, making it the second US state to legalize medical aid in dying (MAID).2 Today, MAID has
become more widely adopted and is officially permitted in 8 jurisdictions in the United States (OR
[1994], WA [2008], Montana [2009], Vermont [2013], California [2015], Colorado [2016], District of
Columbia [2017], and Hawaii [2019]) and will be adopted in New Jersey on August 1, 2019.
Legislative processes inherent within the passage of the DeathWith Dignity Acts in both OR and
WA ensure safeguards for patients seeking MAID, including guaranteeing procedural guidelines for
oversight by local and state agencies.3 Such precautionary measures include requiring the patient to
place 3 separate oral and written requests with a built-in waiting period and a required assessment
to assess decisional capacity in any case in which it is suspect.1,2 However, differences in the
framework of MAID legislation between each state may result in different outcomes, and, to our
knowledge, data on the implementation and uniformity of this practice have never been compared
between 2 US states. Notably, policy researchers in Canada identified significant interprovincial
differences in CanadianMAID program processes and practice.4
Since enactment of MAID legislation in OR andWA, both states mandate publication of an
annual statistical report with information pertaining to patients and physicians who participate in
MAID. Here, we review the combined 28 years of data onMAID from 2 states with the longest history
of establishedMAID legislation to determinemajor patterns of use, compare demographic trends
over time, and evaluate whether they are consistent across both jurisdictions.
Methods
Data Collection
All annual reports published by the Oregon Health Authority and theWashington State Department
of Health, from 1998 to 2017 in Oregon and from 2009 to 2017 in Washington, were reviewed in
their entirety by 4 of us (L.A.R., M.L., T.B., and C.D.B.). The data sets generated and analyzed during
the current study are available on theOregonHealth Authority5 andWashington State Department
of Health6 websites. This study qualified for institutional review board exemption by the Oregon
Health and Science University Office of Integrity as the study used publicly available data in such a
manner that participants could not be identified. This study followed the Strengthening the
Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline for cohort studies.7
Statistical Analysis
Characteristics of those dying as a result of orally ingested lethal medication(s) were first collected
independently by state, and then combined if they differed by less than 5%. Time trends for deaths
from ingesting lethal medication vs number of prescriptions were analyzed using logistic regression.8
The time trends for assessing the changes in deaths per 1000populationwere analyzedwith Poisson
regression where population figures were obtained from state health departments.5,6 Final death
numbers were not available for WA for 2015 and 2016, so they were estimated based onmean
increases over the last 3 years fromWA.
The age distributions of individuals who usedMAIDwere calculated for all years inWA and from
2006 onward for OR given differing age group definitions in earlier OR reporting. A χ2 test statistic
was used to test differences in age distributions for the 2 programs. Trends in changes in the age
distribution between programs were assessed based on logistic regression where patients were
divided in 2 age groups, 75 years and older vs younger than 75 years. All P values reported are
2-sided, with a level of significance of P < .05.
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Results
Over the combined 28 years of publicly available data in OR andWA, 3368 prescriptions were
written, with 2558 patients (76.0%) dying after they ingestedmedication. Persons using MAID were
approximately equally distributed by sex (1311 [51.3%]male), non-Hispanic white individuals were
most commonly represented (2426 patients [94.8%]), most patients were older than 65 years (1851
[72.4%]), and themajority had received some college education (1830 [71.5%]) and were insured
(2264 [88.5%]) at the time of request (Table 1). Age distribution was not statistically significant
between states (Table 2).
Most patients who received prescriptions had a diagnosis of cancer (1955 [76.4%]), while the
remaining had neurologic illness (261 [10.2%]), lung disease (144 [5.6%]), heart disease (117 [4.6%]),
or other illnesses (77 [3.0%]). Themost frequent reasons for requestingMAIDwere loss of autonomy
(2235 [87.4%]), decreasing ability to participate in pleasurable activities or impaired quality of life
(2203 [86.1%]), and loss of dignity (1755 [68.6%]). Four percent of patients received referrals for
psychiatric examinations. Enrollment rates in hospice were high, with 87.8% and 64.2% of patients
enrolled at the time of death in OR andWA, respectively.
Table 1. Patient Characteristics for Oregon andWashingtona
Baseline Characteristic
Participants, No. (%)
(N = 2558)
Sex
Male 1311 (51.2)
Female 1247 (48.8)
Age range, y 20-102
Race
White 2426 (94.8)
Other 101 (3.9)
Unknown 31 (1.2)
Some college education 1830 (71.5)
Medically insured 2264 (88.5)
Oregon 1157 (90.8)
Washington 1107 (81.2)
Underlying illness
Cancer 1955 (76.4)
Neurological condition, eg, amyotrophic
lateral sclerosis
261 (10.2)
Lung disease, eg, chronic obstructive
pulmonary disease
144 (5.6)
Cardiac disease, eg, congestive heart failure 117 (4.6)
Other 117 (3.0)
Enrolled in hospice 1943 (76.0)
a Data include cases from 1998 to 2017 in Oregon and from 2009 to 2017 in
Washington.
Table 2. Age Distribution AmongMedical Aid in Dying Participants
in Oregon andWashington
Age, y
Participants, %
Oregon Washington
18-44 2.5 2.5
45-54 4.5 6.0
55-64 19.7 20.0
65-74 30.8 30.4
75-84 25.6 23.0
≥85 16.9 18.0
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A total of 2075 patients (81%) died at home, and prescribers were present in 247 cases (9.7%
total; 187 [14.7%] in OR and 60 [4.7%] inWA). Time between drug intake and coma ranged from 1 to
660minutes and time from drug intake to death ranged from 1 to 6240 to minutes. From data
reported in the OR data set, median time from ingestion to comawas 5minutes and time from
ingestion to death was 25minutes. Notably, in 638 drug recipients (50.0%) in OR, it was unknown
whether a complication occurred. This is due to a 2010 amendment on the follow-up questionnaire
that only allowed information regarding time of and circumstances surrounding death to be reported
if a clinician was present at time of death. Among 1557 patients for whom complication rates were
reported, 1494 (96%) did not experience a complication (592 of 626 [94.6%] in OR and 902 of 931
[96.8%] inWA). Eight patients (<0.5%) awoke in OR after drug ingestion.
Time TrendAnalyses
We evaluated keymeasures of the 2 programs. Annual rates per year for percentage of patients
ingesting medication ranged from 48% to 87%, with no significant time trend in OR (adjusted odds
ratio per year, 1.01; 95% CI, 0.99-1.02; P = .59) but with an increase over time in WA (adjusted odds
ratio per year, 1.13; 95% CI, 1.08-1.19; P < .001).
We used the participant age distribution partitioned at 75 years or older vs younger than 75
years to evaluate changes over time. There was no significant change in the fraction of individuals
over time in OR (adjusted odds ratio, 1.02; 95% CI, 0.98-1.05; P = .40). In WA there was a
nonsignificant increase (adjusted odds ratio, 1.05; 95% CI, 1.00-1.10; P = .05).
The trends for programs were also calibrated against total state population deaths. In both OR
and WA there were increases in the numbers of patients using MAID per 1000 deaths over time.
Estimates and regression lines from fitted Poisson regressionmodels, using logarithm link to
outcome, are seen in the Figure. The P values for trend for WA and ORwere both less than .001 with
a greater rate of increase in WA with a significant interaction test statistic (OR, 0.94; 95% CI, 0.91-
0.96; P < .001). While annual estimates give some suggestion that the rate of increase is slowing for
both programs in the last 2 years, it will take several more years of follow-up data for this to be
confirmed.
Discussion
Previous reports have detailed MAID use in OR, the state with the longest-running death with dignity
program.9 States such asWAhavemodeled theirMAID legislation after OR’s, but outcomes have not
been extensively detailed or compared. Canada has legalized MAID across the entire country, but
each province or territory independently sets up its policies and procedures, and results to date have
demonstratedwide variability.4 However, the outcomes ofMAID legislation in OR andWAhave been
remarkably similar. The population of terminally ill individuals pursuing MAID is approximately
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equally distributed across sex and predominantly consists of persons aged 65 years and older and
individuals diagnosed with cancer (Table 1 and Table 2). The vast majority are non-Hispanic white
individuals (94.8%) with some level of college education (71.5%), and 88.5%were insured by public
or private programs. These data reinforce the belief that MAID has not been directed toward
traditionally vulnerable populations based on age, race/ethnicity, level of educational attainment, or
insurance status. In addition, the Figure illustrates that with the increasing age of legislation, there
has been a corresponding increase in MAID use in both OR andWA.We can hypothesize that this is a
result of similarMAID legislation in both states and supported by increased public awareness of such
legislation.
Themost notable differences between both states include the number of patients enrolled in
hospice at the time of death, with a greater number of patients enrolled at the time of death in OR
(87.8%) vs WA (64.2%). This may be partially explained by the slightly higher number of insured
patients at the time of enrollment (90.8% in OR vs 81.2% inWA).
Our data set supports the overall safety and reliability of the lethal medications used in MAID.
Among patients who ingested the lethal drugs and were evaluable for complications, only 4%
experienced complications, the most common being difficulty ingesting or regurgitation of the lethal
drug. Intervention by emergencymedical services after the lethal drug was ingested, information
that is only collected byWA, did not occur over a 10-year period. Short median times to
unconsciousness and death prevent undue and lengthy suffering and reflect the efficacy of drugs
used in MAID.
Reasons patients choose to pursueMAID include loss of autonomy, impaired quality of life,
inadequate pain control, and, in a small percentage, financial concerns. The reasons underlyingMAID
may be representative of the larger population of individuals facing the end of life and should be
formally studied. Additionally, MAID research to date has beenmostly descriptive.9,10 Formal
interventional trials are being proposed, including a study assessing the effect of mandatory referral
for treatment of depression onMAID follow-through (Robert S. Krouse, MD, email communication,
May 8, 2019). There is significant room for further integration of palliative care, social support
services, and case management in end-of-life decision-making with the intent of increasing the
options available to those facing a terminal disease. In the 2019 OR legislative session, 3 measures
were introduced pertaining to MAID, including amendments that would redefine the term ingestion
to include anymethod by which a patient introduces a medication into his or her body, eliminate the
6-month period that currently defines terminal disease (Oregon House Bill 2903), define the term
self-administer (Oregon House Bill 2217), and create an exception to the defined waiting periods for
patients who have extremely limited life expectancies (Oregon Senate Bill 579).
Limitations
The quality of our data is limited by the fact that the underlying reasons for requestingMAIDwere not
collected from patients but supplied by physicians in the form a follow-up questionnaire. As such,
there is no way of ascertaining whether the enquiries were comprehensive.
In 2010, an amendment to the follow-up questionnaire in OR only allowed information
regarding time of and circumstances surrounding death to be reported if a clinician was present at
time of death. This has resulted in approximately half of patients having data collected mentioning
complications, which consequently runs a risk of underreporting complications andmakes it difficult
to completely assess the safety surroundingMAID. Some opponents of MAID estimate higher
complication rates and advocate for greater physician involvement, specifically the use of physician-
assisted euthanasia.11
Conclusions
In this study, MAID results in Oregon andWashington were similar, althoughMAID usemeasured as
a percentage of patients prescribed lethal medications and then self-administering them increased
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only inWA. Most patients who acquired lethal prescriptions had cancer or terminal illnesses that are
difficult to palliate and lead to loss of autonomy, dignity, and quality of life. Concerns that MAID
would unintentionally target socially disadvantaged patients have not materialized, as evidenced by
the data presented in this article. States consideringMAID legalizationmay see similar results if they
model their rules on those put into place in the US Pacific Northwest.
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